Pseudomyxoma Peritonei Overview
Learn About Pseudomyxoma Peritonei
- Pseudomyxoma peritonei
- Adenomucinosis
- Gelatinous ascites
- PMP
- Syndrome of pseudomyxoma peritonei
Main Line Healthcare
David Holtz is a Gynecologic Oncologist and an Oncologist in Glen Mills, Pennsylvania. Dr. Holtz and is rated as an Advanced provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Endometrial Cancer, Malignant Mixed Mullerian Tumor, Neonatal Ovarian Cyst, Ovarian Cysts, and Bladder Reconstruction.
Christiana Care Health Services Inc
Mark Cadungog is a Gynecologic Oncologist and an Oncologist in Newark, Delaware. Dr. Cadungog and is rated as an Advanced provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Endometrial Cancer, Vulvar Cancer, Cervical Cancer, Hysterectomy, and Hernia Surgery. Dr. Cadungog is currently accepting new patients.
Raafat Abdel-Misih is a General Surgeon in Newark, Delaware. Dr. Abdel-Misih and is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Hyperparathyroidism, Neuroendocrine Tumor, Familial Pancreatic Cancer, Parathyroidectomy, and Pancreatectomy.
Summary: The main objective of this study is to combine HIPEC regimens with Flura-seq to detect the effects of different HIPEC regimens (cisplatin vs. cisplatin+ docetaxel) on the nascent transcriptome of PMP tumors, so as to quantitatively assess the efficacy of different HIPEC regimens in the early stage, and to lay the foundation for optimizing the HIPEC regimens and exploring new therapeutic targets.
Summary: The goal of this clinical trial is to investigate the effect of gastrointestinal stimulation with a pacemaker on the length of postoperative bowel paralysis in patients undergoing major abdominal surgery due to metastasizing colorectal cancer, appendiceal cancer or pseudomyxoma peritonei. The main question it aims to answer is if the length of postoperative ileus is reduced when the gastrointestin...
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center